Stevanato Group

Piombino Dese, Italy Founded: 1949 • Age: 77 yrs
Pharmaceutical products, wearables, and inhalers are manufactured globally.
Annual revenue $1.2B Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Stevanato Group

Stevanato Group is a company based in Piombino Dese (Italy) founded in 1949. Stevanato Group offers products and services including Drug Containment Solutions and Drug Delivery Systems.

  • Headquarter Piombino Dese, Italy
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Stevanato Group S.P.A.
Operational Areas
Healthcare → Medical Devices & Diagnostics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $1.19 B (USD)
    1.78
    as on Dec 31, 2024
  • Net Profit
    $127.4 M (USD)
    -19.08
    as on Dec 31, 2024
  • EBITDA
    $251.71 M (USD)
    -13.37
    as on Dec 31, 2024
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Stevanato Group

Stevanato Group is a publicly listed company on the NYSE with ticker symbol STVN in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NYSE · Ticker: STVN · Sector: Health technology · USA

Products & Services of Stevanato Group

Stevanato Group offers a comprehensive portfolio of products and services, including Drug Containment Solutions and Drug Delivery Systems.

Product name locked
Category locked
Primary

Drug containment solutions are manufactured for glass primary packaging, including vials and syringes, to support the pharmaceutical industry.

Product name locked
Category locked
Locked

Drug delivery systems are developed, including auto-injectors and pen injectors, to facilitate the administration of pharmaceutical products.

People of Stevanato Group

Headcount 1000-5000
Employee Profiles 228
Board Members and Advisors 9
Employee Profiles
People
Matteo Crespan
Continuous Improvement And Process Engineering Coordinator
People
Michele Celeghin
Project Manager In Erp Infor LN
People
Nicola Volpato
Project Manager IT
People
Elena Soldà
HR Data Management

Unlock access to complete

Board Members and Advisors
people
Alvise Spinazzi
Independent Director
people
Madhavan Balachandran
Independent Director
people
Sergio Stevanato
Chairman of the Board Emeritus
people
Paola Vezzaro
Independent Director

Unlock access to complete

Funding Insights of Stevanato Group

Premium access

Detailed funding history for Stevanato Group

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Stevanato Group

Investments
Premium access

Investment portfolio details for Stevanato Group

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Stevanato Group

Premium access

Detailed financials for Stevanato Group

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Stevanato Group Comparisons

Stevanato Group Primary company
Description
Pharmaceutical products, wearables, and inhalers are manufac...
Location
Piombino Dese, Italy
Founded Year
1949
Annual Revenue
$1.19 B (USD)
Net Profit
$127.4 M (USD)
EBITDA
$251.71 M (USD)
Employees
Not available
Premium access

Peer comparison for Stevanato Group

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Stevanato Group

Premium access

Detailed competitors of Stevanato Group

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Stevanato Group

Premium access

Complete news archive for Stevanato Group

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Stevanato Group

Stevanato Group was founded in 1949.

Stevanato Group is headquartered in Piombino Dese, Italy. It is registered at Piombino Dese, Veneto, Italy.

Annual revenue of Stevanato Group is $1.19B as on Dec 31, 2024.

Stevanato Group was founded in 1949 in Piombino Dese, Italy, and operates within the pharmaceutical manufacturing sector. Precision glass containers, syringes, and delivery systems for injectable drugs are produced, alongside components for wearables and inhalation devices. Operations span design, production, and supply chain management, with facilities focused on quality standards for medical applications. International distribution supports healthcare and biotech industries from its Italian base.

Stevanato Group offers Drug Containment Solutions and Drug Delivery Systems.

Yes, Stevanato Group is publicly traded on NYSE under the ticker symbol STVN.

The ticker symbol of Stevanato Group is STVN on NYSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available